Selected article for: "antiviral activity and entry process"

Author: Leclercq, Loïc
Title: Interactions between cyclodextrins and cellular components: Towards greener medical applications?
  • Document date: 2016_12_7
  • ID: 16pzlvzz_69
    Snippet: Cholesterol levels in the plasma membrane are extremely important in many parts of the viral infection process such as the entry and release of virions from the host cell as well as for the transport of various viral proteins. CDs have a clear antiviral activity against influenza virus [140] , human immunodeficiency virus (HIV-1) [141] , murine corona virus [142] , poliovirus [143] , human T cell leukemia virus (HTLV-1) [144] , Newcastle virus [1.....
    Document: Cholesterol levels in the plasma membrane are extremely important in many parts of the viral infection process such as the entry and release of virions from the host cell as well as for the transport of various viral proteins. CDs have a clear antiviral activity against influenza virus [140] , human immunodeficiency virus (HIV-1) [141] , murine corona virus [142] , poliovirus [143] , human T cell leukemia virus (HTLV-1) [144] , Newcastle virus [145, 146] , varicella-zoster [147] , duck and human hepatitis B virus [148, 149] , bluetongue virus [150] , etc. In these cases, the ability of CDs to decrease membrane cholesterol was proposed as antiviral mechanism. Nevertheless, the biological effects of the CDs can be classified according to their role: i) to impede the viral entry in the host cell, ii) to decrease the relative infectivity of the virions, iii) to decrease the observed viral titer, and iv) to disrupt the surface transport of influenza virus hemagglutinin. Few typical examples of the CD effect on the pathogenicity of several viruses are reported.

    Search related documents:
    Co phrase search for related documents
    • antiviral activity and bluetongue virus: 1
    • antiviral activity and cell leukemia: 1, 2, 3, 4, 5
    • antiviral activity and Cholesterol level: 1
    • antiviral activity and corona virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and host cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and host cell viral entry: 1, 2, 3, 4, 5, 6
    • antiviral activity and host cell virion: 1, 2
    • antiviral activity and human immunodeficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and human immunodeficiency virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral mechanism and cd ability: 1
    • antiviral mechanism and corona virus: 1, 2, 3, 4, 5
    • antiviral mechanism and host cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral mechanism and host cell viral entry: 1, 2
    • antiviral mechanism and human immunodeficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antiviral mechanism and human immunodeficiency virus: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • biological effect and host cell: 1, 2, 3, 4
    • bluetongue virus and host cell: 1, 2, 3, 4, 5
    • bluetongue virus and human immunodeficiency: 1
    • cd ability and CD effect: 1, 2